233 related articles for article (PubMed ID: 10871325)
1. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
[TBL] [Abstract][Full Text] [Related]
2. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
3. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
4. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
5. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.
Hervás I; Vilaró MT; Romero L; Scorza MC; Mengod G; Artigas F
Neuropsychopharmacology; 2001 Jan; 24(1):11-20. PubMed ID: 11106871
[TBL] [Abstract][Full Text] [Related]
7. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
[TBL] [Abstract][Full Text] [Related]
9. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
[TBL] [Abstract][Full Text] [Related]
11. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
[TBL] [Abstract][Full Text] [Related]
12. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
Zhang Y; D'Souza D; Raap DK; Garcia F; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2001 Oct; 21(20):7919-27. PubMed ID: 11588165
[TBL] [Abstract][Full Text] [Related]
14. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
[TBL] [Abstract][Full Text] [Related]
15. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
Gur E; Lifschytz T; Van De Kar LD; Lerer B; Newman ME
Psychoneuroendocrinology; 2004 Oct; 29(9):1172-83. PubMed ID: 15219641
[TBL] [Abstract][Full Text] [Related]
16. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
Newman ME; Shalom G; Ran A; Gur E; Van de Kar LD
Eur J Pharmacol; 2004 Feb; 486(1):25-30. PubMed ID: 14751404
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
18. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus.
Raap DK; DonCarlos L; Garcia F; Muma NA; Wolf WA; Battaglia G; Van de Kar LD
Neuropharmacology; 2000 Jul; 39(10):1823-32. PubMed ID: 10884563
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.
Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA
J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
Fernández-Pérez S; Pache DM; Sewell RD
Eur J Pharmacol; 2005 Oct; 522(1-3):78-83. PubMed ID: 16214127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
